GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Short-Term Debt & Capital Lease Obligation

Kindstar Globalgene Technology (HKSE:09960) Short-Term Debt & Capital Lease Obligation : HK$225 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Kindstar Globalgene Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$225 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Kindstar Globalgene Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$34 Mil.


Kindstar Globalgene Technology Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Kindstar Globalgene Technology's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Short-Term Debt & Capital Lease Obligation Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial 315.15 73.07 10.24 213.29 180.51

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.24 12.51 213.29 224.60 180.51

Kindstar Globalgene Technology Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Kindstar Globalgene Technology Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology (HKSE:09960) Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines